Medical Equipment

Cardiac Marker Market Forecast Highlighting Demand And Industry Growth

April 10, 2026April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Cardiac Marker Market During The Forecast Period?

The cardiac marker market has shown substantial expansion in recent years. It is anticipated to increase from $12.38 billion in 2025 to $13.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. Historically, this growth can be attributed to the rising burden of cardiovascular diseases, the expansion of hospital laboratory infrastructure, an increased use of emergency cardiac testing, a growing reliance on biomarker-based diagnosis, and improvements in assay sensitivity.

The cardiac marker market is projected to experience swift expansion over the coming years. This market is anticipated to reach $22.7 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This expansion during the projection period stems from a heightened need for quicker diagnostic test results, the growing incorporation of cardiac diagnostics into digital platforms, the proliferation of point-of-care testing locations, the increasing uptake of sophisticated biomarker panels, and a greater emphasis on precision cardiology. Key trends expected over the forecast horizon encompass a rise in the utilization of highly specific cardiac marker panels, the increasing embrace of automated immunoassay systems, a growing requirement for swift cardiac diagnoses, the broadening of multiparametric testing methodologies, and an elevated concentration on clinical decision support.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

What Major Factors Are Driving The Cardiac Marker Market Forward?

The increasing occurrence of cardiac diseases is anticipated to drive the expansion of the cardiac marker market in the foreseeable future. Cardiac diseases encompass a variety of conditions that affect the heart’s structure or operation, resulting in diverse medical problems. Cardiac markers are employed for diagnosing and monitoring numerous cardiac conditions, such as heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, the demand for diagnostic tests, particularly cardiac markers, has risen. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the escalating prevalence of cardiac diseases will fuel the cardiac marker market’s growth.

How Are Different Segments Classified In The Cardiac Marker Market Segment Analysis?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Which Trends Are Impacting The Progress Of The Cardiac Marker Market?

Leading companies in the cardiac marker market are prioritizing innovative products like high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers to increase their market revenues. High-sensitivity troponin I (hs-cTnI) and NT-proBNP are vital cardiac biomarkers utilized for diagnosis, classification, and treatment. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based firm specializing in the development, manufacturing, and distribution of medical equipment and solutions, introduced troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has surpassed the minimum requirements for hs-cTn in terms of its sensitivity, accuracy, and reliability for identifying myocardial damage. These new products aim to support improved treatment for cardiovascular illnesses by delivering dependable solutions that enhance patient outcomes both within and outside the scope of cardiovascular diseases.

Who Are The Companies Driving Activity In The Cardiac Marker Market?

Major companies operating in the cardiac marker market are Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMérieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, Creative Diagnostics

Get The Full Cardiac Marker Market Report:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

Which Region Has The Greatest Market Share In The Cardiac Marker Market?

North America was the largest region in the cardiac marker market in 2025. The regions covered in the cardiac marker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cardiac Marker Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Browse Through More Reports Similar to the Global Cardiac Marker Market 2026, By The Business Research Company

Arrhythmia Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report

Cardiac Arrhythmia Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Wearable Heart Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795